Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development
- PMID: 3011271
- DOI: 10.1016/0092-8674(86)90280-1
Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development
Abstract
We have constructed a transgenic mouse strain in which a mammary tumor virus LTR/c-myc fusion gene is anomalously expressed in a wide variety of tissues. The deregulated c-myc transgene, now glucocorticoid inducible, contributes to an increased incidence of a variety of tumors, including those of testicular, breast, lymphocytic (B cell and T cell), and mast cell origin. The deregulated gene does not, however, otherwise disturb cell proliferation, nor does it interfere with normal development in these animals. Moreover, since not all tissues that express the transgene develop neoplasms, these results begin to define the transforming spectrum of the c-myc oncogene. They also extend to several organ systems the notion that elements in addition to an activated c-myc gene are required to induce malignancy in the living organism.
Similar articles
-
Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.Cell Growth Differ. 1995 Jun;6(6):737-48. Cell Growth Differ. 1995. PMID: 7669729
-
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.Nat Med. 2001 Feb;7(2):235-9. doi: 10.1038/84691. Nat Med. 2001. PMID: 11175856
-
The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.Oncogene. 1995 Jul 6;11(1):181-90. Oncogene. 1995. PMID: 7624126
-
TGF beta regulation of cell proliferation.Princess Takamatsu Symp. 1994;24:250-63. Princess Takamatsu Symp. 1994. PMID: 8983080 Review.
-
Proto-neoplasia revisited: the molecular biology of mouse mammary hyperplasia.Anticancer Res. 1988 Sep-Oct;8(5A):925-33. Anticancer Res. 1988. PMID: 2845853 Review.
Cited by
-
Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.Proc Natl Acad Sci U S A. 1988 Aug;85(16):6047-51. doi: 10.1073/pnas.85.16.6047. Proc Natl Acad Sci U S A. 1988. PMID: 3261863 Free PMC article.
-
Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation.Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3728-33. doi: 10.1073/pnas.0910665107. Epub 2010 Feb 3. Proc Natl Acad Sci U S A. 2010. PMID: 20133707 Free PMC article.
-
Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.Cancer Res. 2008 Feb 15;68(4):1064-73. doi: 10.1158/0008-5472.CAN-07-5892. Cancer Res. 2008. PMID: 18281481 Free PMC article.
-
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.J Exp Med. 1993 Sep 1;178(3):1057-65. doi: 10.1084/jem.178.3.1057. J Exp Med. 1993. PMID: 8350046 Free PMC article.
-
MYC on the path to cancer.Cell. 2012 Mar 30;149(1):22-35. doi: 10.1016/j.cell.2012.03.003. Cell. 2012. PMID: 22464321 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases